Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

XBB .1.5 neutralizing antibodies upon bivalent COVID ‐19 vaccination are similar to XBB but lower than BQ .1.1

22 Feb 2023

Abstract excerpt

The COVID-19 virus has evolved significantly from the ancestral WA1/2020 strain over the past 3 years with new sublineages, subvariants, and recombinant strains emerging and causing new waves of infections.1 During 2022, the Omicron B.1.1.529 sublineages have been spreading world-wide and a recent emerging rapidly spreading XBB.1.5 variant has been reported (www.gisaid.org). This prompted the analysis of vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36810791
DOI: 10.1002/ajh.26887

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

XBB .1.5 neutralizing antibodies upon bivalent COVID ‐19 vaccination are similar to XBB but lower than BQ .1.1PMID 36810791Read ↗

The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSemantic proximity Read ↗

Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1Semantic proximity Read ↗

Is the BNT162b2 vaccine still effective against the latest variant: XBB.1.5?Semantic proximity Read ↗

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariantsSemantic proximity Read ↗

Humoral Immunity Elicited by the XBB.1.5 Monovalent COVID-19 VaccineSemantic proximity Read ↗

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1Semantic proximity Read ↗

SARS-CoV-2 Omicron BA.2.86: less neutralization evasion compared to XBB sub-variantsSemantic proximity Read ↗

Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccineSemantic proximity Read ↗

Continued evasion of neutralizing antibody response by Omicron XBB.1.16Semantic proximity Read ↗

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionSemantic proximity Read ↗

Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population levelSemantic proximity Read ↗

Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 VaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.